During this unprecedented time, many researchers are having to consider alternative methods in which to conduct their research. This may include considering clinical trial participants' needs due to self-isolation, travel restrictions or reluctance to attend a Public Health Organisation at this time.
Clinical trial sponsors, sites and researchers should be guided by the procedures outlined in the Office for Health and Medical Research (OHMR) guidance document on the impact of COVID-19 on the conduct of clinical trials.
The NSLHD Human Research Ethics Committee (HREC), the NSLHD Animal Ethics Committee (AEC) and the (RNSH) Institutional Biosafety Committee (IBC) continue to operate as per the dates and deadlines on the NSLHD Research Office website, observing current requirements for social distancing.
In this constantly changing environment please continue to check the [email protected] auto email reply and the NSLHD Research Ethics and Governance website for the most up to date information from the Research Office.